Perspective Therapeutics Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$2.91

-0.08 (-2.68%)

As of Aug 8, 1:52 AM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 18 90%

Hold 2 10%

Sell 0 0%

Price Target

Analyst Price Target +575.9% upside

Low Target $12.33

Average Target $19.67

High Target $23.14

Current Price $2.91

Current
$2.91

Target
$19.67

$12.33 $19.67 avg $23.14

Scenario Analysis

Bear Case

$12.33

323.7%

Low target

Base Case

$19.67

+575.9%

Avg target

Bull Case

$23.14

+695.2%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$6.16

-52.8% from high

52-Week Low

$1.96

+48.5% from low

Target vs 52W High

$19.67

+219.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	79%	$257.58	+4.7%
AMGN Amgen Inc	Hold	43	49%	$190.87	-53.6%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+172.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.6%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-90.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-55.6%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-44.4%
BIIB Biogen Inc	Buy	44	64%	$91.45	-56.0%